Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Detection of Minimal Residual Disease in Acute Myeloid Leukemia: Evaluating Utility and Challenges

PROVIDER: PRJNA1120383 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR29293602.fastq.gz	Fastqsanger.gz
	SRR29293603.fastq.gz	Fastqsanger.gz
	SRR29293604.fastq.gz	Fastqsanger.gz
	SRR29293605.fastq.gz	Fastqsanger.gz
	SRR29293606.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 59

Similar Datasets

Homo sapiens

Project description:New markers for minimal residual disease detection in acute lymphoblastic leukemia

| PRJNA139293 | ENA

Project description:FLT3-TKD measurable residual disease in acute myeloid leukemia

| PRJNA979814 | ENA

Project description:Measurable/minimal residual disease monitoring by next-generation sequencing in patients with acute myeloid leukemia

| PRJNA719439 | ENA

Search for New Biomarkers for the Monitoring of the Minimal Residual Disease of the Acute Lymphoblastic Leukemia.

Project description:The main goal of the research was to find some new biomarkers for the monitoring of the Minimal Residual Disease in Acute Lymphoblastic Leukemia patients. Keywords: Search for new Biomarkers

2008-03-15 | GSE10820 | GEO

caArray_willm-00140: TARGET-ALL Expression: Children's Oncology Group Study 9906 for High-Risk Pediatric ALL

2015-05-12 | GSE68735 | GEO

Project description:Measurable Residual Disease in IDH mutated Acute Myeloid Leukemia patients

| PRJNA998386 | ENA

Homo sapiens

Project description:Minimal Residual Disease in a Novel Xenograft Model of RUNX1-mutated, Cytogenetically Normal Acute Myeloid Leukemia

| PRJNA275147 | ENA

caArray_willm-00140: TARGET-ALL Expression: Children's Oncology Group Study 9906 for High-Risk Pediatric ALL

Project description:Gene Expression Classifiers for Minimal Residual Disease and Relapse Free Survival Improve Outcome Prediction and Risk Classification in Children with High Risk Acute Lymphoblastic Leukemia: A Children's Oncology Group Study willm-00140 Assay Type: Gene Expression Provider: Affymetrix Array Designs: HG-U133_Plus_2 Organism: Homo sapiens (ncbitax) Tissue Sites: Blood, Bone marrow Material Types: Peripheral Blood, Bone Marrow Disease States: Childhood Precursor B-Lymphoblastic Leukemia

2015-05-12 | E-GEOD-68735 | biostudies-arrayexpress

Mullighan TXVI RNASEQ - samples

Project description:RNASeq files for paper titled "Prognostic and therapeutic significance of leukemia subtypes and minimal residual disease measurements in pediatric acute lymphoblastic leukemia treated with contemporary risk-directed trial: a cohort study"

| EGAD00001006609 | EGA

Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia.

Project description:Neural cell adhesion molecule 1 (NCAM1; also known as CD56) is expressed in up to 20% of acute myeloid leukemia (AML) patients. Expression of NCAM1 is widely used as a marker of minimal residual disease; however, the biological function of this cell surface protein in AML remains elusive. In this study we investigated the impact of aberrant NCAM1 expression on leukemogenesis, drug resistance and its role as a biomarker to guide therapy.Gene expression profiling was performed with RNA-seq in three cell lines (SKM-1, NOMO-1, MOLM-14) after doxycycline-mediated induction of scrambled shRNA or shNCAM1 at timepoint 72 hours.

2019-02-22 | GSE123071 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data